Serum (1→3)-β-D-glucan measurement in coccidioidomycosis

George R. Thompson, Derek J. Bays, Suzanne M. Johnson, Stuart H. Cohen, Demosthenes Pappagianis, Malcolm A. Finkelman

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

The serum (1→3)-β-D-glucan assay has emerged as an important diagnostic test for invasive fungal disease. The utility of this assay in coccidioidomycosis has not been previously studied. Using a cutoff value of ≥80 pg/ml, we found the sensitivity (43.9%), specificity (91.1%), positive predictive value (81.8%), and negative predictive value (64.1%) to be similar to those of the assay in diagnosing other invasive mycoses.

Original languageEnglish (US)
Pages (from-to)3060-3062
Number of pages3
JournalJournal of clinical microbiology
Volume50
Issue number9
DOIs
StatePublished - Sep 1 2012
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Serum (1→3)-β-D-glucan measurement in coccidioidomycosis'. Together they form a unique fingerprint.

  • Cite this

    Thompson, G. R., Bays, D. J., Johnson, S. M., Cohen, S. H., Pappagianis, D., & Finkelman, M. A. (2012). Serum (1→3)-β-D-glucan measurement in coccidioidomycosis. Journal of clinical microbiology, 50(9), 3060-3062. https://doi.org/10.1128/JCM.00631-12